未知股票 GNFT 深 滬
等待開盤
--
0.000
NaN.00%
華盛通- 最 高--
- 今 開--
- 成交量 --
- 最 低 --
- 昨 收 --
- 總市值 0
- 52周最高 --
- 市盈率 靜 0.00
- 換手率 0.00%
- 52周最低 --
- 委 比 0.00%
- 總股本 5000.29万
- 歷史最高 --
- 量 比 0
- 振 幅 NaN.00%
- 歷史最低 --
- 每 手 1
- 風險率 0.31%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Genfit adds $20M as Ipsen records strong sales for liver drug
Genfit (GNFTY) (GNFTF) closed higher in Europe on Thursday after the French biotech said that it is entitled to a $20M payment from partner Ipsen (IPSEY) due to the stronger-than-expected commercial p...
02-13 02:52
BRIEF-Genfit Announces Effectiveness Of Delisting Of American Depositary Shares From Nasdaq
Nov 20 (Reuters) - Genfit SA GNFT.PA: GENFIT ANNOUNCES EFFECTIVENESS OF VOLUNTARY DELISTING OF AMERICAN DEPOSITARY SHARES FROM NASDAQ STOCK MARKET Source text: ID:nGNX77mrY7 Further company coverage: ...
2025-11-21 02:14
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Kazia Therapeutics (NASDAQ:KZIA) shares increased by 51.6% to $8.73 du...
2025-11-19 20:05
Viking Therapeutics, Genfit, Sagimet jump as Novo to buy Akero
Viking Therapeutics (NASDAQ:VKTX) and other biotechs advancing drugs for a liver disease called metabolic dysfunction-associated steatohepatitis (MASH) gained on Thursday as the MASH space witnessed t...
2025-10-09 23:33
美股大行评级 | 217美元！花旗上调阿里巴巴目标价；多家机构集体上调麦克森、美光科技等目标价
今日重点评级关注：Ascendiant Capital：维持Maison Solutions"买入"评级，目标价从4美元升至4.25美元；瑞穗：维持MBX Biosciences"跑赢大市"评级，目标价从38美元升至56美元
2025-09-25 09:52
Genfit H1 EPS $(0.23) Down From $0.57 YoY, Sales $40.443M Down From $65.887M YoY
Genfit (NASDAQ:GNFT) reported quarterly losses of $(0.23) per share. This is a 140.35 percent decrease over earnings of $0.57 per share from the same period last year. The company reported $40.443 million in sales this
2025-09-23 04:11
Earnings Scheduled For September 22, 2025
Companies Reporting Before The Bell Companies Reporting After The Bell • Genfit...
2025-09-22 16:32
HC Wainwright & Co. Assumes Genfit at Buy, Announces Price Target of $9
HC Wainwright & Co. analyst Brandon Folkes assumes Genfit (NASDAQ:GNFT) with a Buy rating and announces Price Target of $9.
2025-08-19 19:13
GENFIT Releases 2024 Annual Reports, Enhancing Transparency
Genfit SA ( ($GNFT) ) just unveiled an announcement. On April 29, 2025, GENFIT ...
2025-04-30 03:27
BRIEF-Royalty Financing with HCRx: GENFIT Announces Approval of the Amendment of the Terms and Conditions of its 2025 OCEANEs
March 10 (Reuters) - Genfit SA GNFT.PA: ROYALTY FINANCING WITH HCRX: GENFIT ANNOUNCES APPROVAL OF THE AMENDMENT OF THE TERMS AND CONDITIONS OF ITS 2025 OCEANES Source text: ID:nGNX9fmmJx Further compa...
2025-03-11 05:30
